Related Experiment Video
Updated: Dec 10, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences
Ryu Watanabe1,2, Gerald J Berry3, David H Liang1
1Department of Medicine, Stanford University School of Medicine, CCSR Building Room 2225, 269 Campus Drive West, Stanford, CA, 94305-5166, USA.
Insights
Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are distinct autoimmune diseases affecting large arteries. While sharing some features, they differ in immune cell involvement, disease mechanisms, and require specific diagnostic and management strategies.
Area of Science:
- Immunology
- Rheumatology
- Vascular Biology
Background:
- Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are autoimmune diseases targeting medium and large arteries.
- Both involve CD4+ T cells and macrophages forming granulomas in the arterial wall, with potential systemic acute phase responses (e.g., elevated ESR, CRP).
- The relationship between GCA and TAK, whether on a disease spectrum or distinct entities, remains unclear.
Purpose of the Study:
- To review and compare the distinct disease mechanisms, genetic, and epidemiological differences between GCA and TAK.
- To elucidate the immune cell composition and effector pathways involved in arterial wall damage in GCA and TAK.
- To determine if GCA and TAK represent fundamentally different disease processes requiring distinct diagnostic and management approaches.
Main Methods:
- Comparative analysis of existing literature on GCA and TAK.
- Review of immunological and histopathological findings in arterial lesions.
- Examination of genetic, epidemiological, and clinical data.
Main Results:
- GCA and TAK exhibit significant differences in genetics, epidemiology, and disease mechanisms.
- Immune cell infiltration differs, with TAK featuring CD8+ T cells and natural killer cells, unlike GCA.
- These distinct cellular components suggest separate pathways for tissue damage and vascular remodeling.
Conclusions:
- Despite overlapping clinical and histopathological features, GCA and TAK are distinct vasculitides.
- Separate disease mechanisms necessitate disease-specific diagnostic and management strategies.
- Understanding these differences is crucial for targeted therapeutic interventions.
Purpose Of Review:
Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are auto-inflammatory and autoimmune diseases with a highly selective tissue tropism for medium and large arteries. In both diseases, CD4+ T cells and macrophages form granulomatous lesions within the arterial wall, a tissue site normally protected by immune privilege. Vascular lesions can be accompanied by an extravascular component, typically an intense hepatic acute phase response that produces well-known laboratory abnormalities, e.g., elevated ESR and CRP. It is unclear whether GCA and TAK lie on a spectrum of disease or whether they represent fundamentally different disease processes.
Recent Findings:
GCA and TAK share many clinical features, but there are substantial differences in genetics, epidemiology, disease mechanisms, response to treatment, and treatment complications that give rise to different disease trajectories. A significant difference lies in the composition of the wall-infiltrating immune cell compartment, which in TAK includes a significant population of CD8+ T cells as well as natural killer cells, specifying disparate disease effector pathways mediating tissue damage and vessel wall remodeling. Despite the similarities in tissue tropism and histomorphology, GCA and TAK are two distinct vasculitides that rely on separate disease mechanisms and require disease-specific approaches in diagnosis and management.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

